Nursing

Name of Drug Classification Mechanism of Action Indication Contraindication Side Effects Responsibilities
Generic Name: Pharmacologic Necessary for formation of General Indications: Treatment of pernicous When used orally at Before:
Folic Acid Class: coenzymes in metabolic • Folic acid deficiency anemia in patients where appropriate doses, folic  Assess vital
water soluble vitamins systems (purine and • necessary for proper vitamin B12 is deficient. acid is likely safe. signs.
Trade/Brand Name: pyrimidine synthesis protein and DNA Hypersensitivity to Folic Oral use of folic acid can  Assess for
FA-8, Folacin-800 Therapeutic Class: required for maintenance in synthesis, cellular growth Acid. cause: medical history,
antianemics erythropoiesis); stimulates and vitamin B12 function  Bad taste in your especially of
Patient’s Dose: vitamins platelet production in folate Interactions drugs mouth kidney disease
1 tab OD deficiency anemia Possible interactions  Nausea  Inform the
Patient Indication: include:   Loss of appetite purpose of the
Route: Enhances elimination of To correct anemia in  Confusion drug.
PO, IM & IV formic acid in methanol patient after receiving Anticonvulsants. Taking  Irritability  Check for
toxicity via provision of chemotherapy and to folic acid with  Sleep pattern doctor’s orders
Maximum Dosage: coenzyme to folate prevent folic acid fosphenytoin (Cerebyx), disturbance  Assess for
800 mcg orally, dehydrogenase deficiency. phenytoin (Dilantin, hypersensitivities
intramuscularly, Phenytek) or primidone People with allergies
subcutaneously or IV Therapeutic Effects: (Mysoline) might might have a reaction to During:
once a day. Reduces gastric acid decrease the drug's folic acid supplements.  Observe aseptic
secretion and increases concentration in your Warning signs of an technique.
Minimum Dosage: gastric mucus and blood. allergic reaction include:
 Give the right dose at
400 mcg orally, bicarbonate production,  Skin rash
the right time to the
intramuscularly, creating a protective coating Barbiturates. Taking  Itching
right patient.
subcutaneously or IV on gastric mucosa folic acid with a drug that  Redness
once a day. acts as a central nervous  Difficulty
After:
system depressant breathing
 Report for any
Half-life: unknown (barbiturate) might Excess folic acid is
adverse effects
Availability: decrease the drug's excreted in urine.
 Instruct px not to
tablet Absorption: effectiveness. A high folate intake can
double dose when
 400mcg Absorbed in proximal part mask vitamin B-12
there is a missed
 800mcg of small intestine Methotrexate (Trexall). deficiency until its
dose
 1mg Taking folic acid with neurological effects
 Instruct px to store
Metabolism: this medication used to become irreversible. This
at room
injectable solution Metabolized in liver treat cancer could can typically be remedied
temperature away
 5mg/mL interfere with its by taking a supplement
from light and
Elimination: effectiveness. containing 100 percent of
moisture
Content: Excretion: Urine the daily value of both
Folic acid, USP, N-[p- Pyrimethamine folic acid and vitamin B-
[[(2-amino-4- hydroxy-6- (Daraprim). Taking folic 12.
pteridinyl) methyl]- Time/Action Profile: acid with this
amino] benzoyl]- ROUTE ONSET PEAK DURATION antimalarial drug might
Lglutamic acid, is a B reduce the effectiveness
complex vitamin PO Unknown
30-6o Unknown of the drug.
mins
containing a pteridine 30-6o
moiety linked by a IM Unknown
mins
Unknown

methylene bridge to IV Unknown

30-6o Unknown
mins
para-aminobenzoic acid,
which is joined by a
peptide linkage to
glutamic acid.

Source:
Source: Source: Source: Source:
Source: 2015 nurse's drug
2015 nurse's drug 2015 nurse's drug 2015 nurse's drug 2015 nurse's drug handbook (14th ed.).
handbook (14th ed.). handbook (14th ed.). 2015 nurse's drug handbook handbook (14th ed.). handbook (14th ed.). (2015). Burlington, MA:
(2015). Burlington, (2015). Burlington, (14th ed.). (2015). (2015). Burlington, (2015). Burlington, Jones & Bartlett
MA: Jones & Bartlett MA: Jones & Burlington, MA: Jones & Source: MA: Jones & Bartlett MA: Jones & Bartlett Learning.
Learning. Bartlett Learning. Bartlett Learning. Learning. Learning.
2015 nurse's drug Schull, P. D. (2013).
Schull, P. D. (2013). Schull, P. D. (2013). Schull, P. D. (2013). handbook (14th ed.). Schull, P. D. (2013). Schull, P. D. (2013). McGraw-Hill nurses
McGraw-Hill nurses McGraw-Hill McGraw-Hill nurses drug (2015). Burlington, McGraw-Hill nurses McGraw-Hill nurses drug handbook (7th ed.).
drug handbook (7th nurses drug handbook (7th ed.). New MA: Jones & Bartlett drug handbook (7th drug handbook (7th New York: McGraw-Hill
ed.). New York: handbook (7th ed.). York: McGraw-Hill Learning. ed.). New York: ed.). New York: Medical
McGraw-Hill Medical. New York: Medical McGraw-Hill Medical. McGraw-Hill Medical.
McGraw-Hill Schull, P. D. (2013).
Medical. McGraw-Hill nurses
drug handbook (7th
ed.). New York:
McGraw-Hill Medical.